Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Retinoblastoma
Stage/Subtype:  recurrent retinoblastoma
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Results 1-9 of 9 for your search:
Start Over
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 2013-062, NCI-2013-02001, P30CA022453, NCT01987596
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 05-122, MSKCC-05122, NCT00445965
ODSH + ICE Chemotherapy in Pediatric Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Active
Age: 1 to 21
Sponsor: Other
Protocol IDs: NYMC-165, NCT02164097
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 29
Sponsor: Other
Protocol IDs: IRB00078790, NCT02390843
A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 08-885, no grant, NCT00857519
Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: 10 and under
Sponsor: Other
Protocol IDs: RELRB1, NCT00980551
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Phase: No phase specified
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: 2011OC057, MT2011-09C, NCT01505569
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
Phase: No phase specified
Type: Treatment
Status: Active
Age: 5 to 21
Sponsor: Other
Protocol IDs: 201209088, NCT01661400
Start Over